J. P. Lamagnere

547 total citations
19 papers, 407 citations indexed

About

J. P. Lamagnere is a scholar working on Pathology and Forensic Medicine, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. P. Lamagnere has authored 19 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Hematology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. P. Lamagnere's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). J. P. Lamagnere is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). J. P. Lamagnere collaborates with scholars based in France. J. P. Lamagnere's co-authors include Philippe Colombat, Claude Linassier, Isabelle Desbois, C Binet, C. Ropars, Guillaume Cartron, Roger Kravtzoff, Luc Douay, Lotfi Benboubker and Martine Delain and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal of Haematology.

In The Last Decade

J. P. Lamagnere

19 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Lamagnere France 10 146 142 137 97 85 19 407
Isabelle Desbois France 12 96 0.7× 203 1.4× 136 1.0× 113 1.2× 62 0.7× 26 415
F. M. Fink Austria 11 70 0.5× 190 1.3× 68 0.5× 60 0.6× 125 1.5× 21 439
Norbert-Claude Gorin France 8 80 0.5× 145 1.0× 108 0.8× 150 1.5× 82 1.0× 13 439
Jacopo Olivieri Italy 11 82 0.6× 134 0.9× 74 0.5× 81 0.8× 75 0.9× 24 374
Alessia Tabarrini Italy 8 115 0.8× 228 1.6× 93 0.7× 133 1.4× 209 2.5× 9 493
S Murea Germany 11 115 0.8× 325 2.3× 237 1.7× 92 0.9× 68 0.8× 17 529
Brent Kern United States 8 56 0.4× 208 1.5× 232 1.7× 97 1.0× 84 1.0× 12 515
Ivan P. Law United States 10 133 0.9× 82 0.6× 96 0.7× 109 1.1× 48 0.6× 15 342
Agnès Chassevent France 10 103 0.7× 235 1.7× 211 1.5× 92 0.9× 169 2.0× 13 785
Gerlinde Mitterbauer‐Hohendanner Austria 10 61 0.4× 327 2.3× 99 0.7× 215 2.2× 88 1.0× 20 530

Countries citing papers authored by J. P. Lamagnere

Since Specialization
Citations

This map shows the geographic impact of J. P. Lamagnere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Lamagnere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Lamagnere more than expected).

Fields of papers citing papers by J. P. Lamagnere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Lamagnere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Lamagnere. The network helps show where J. P. Lamagnere may publish in the future.

Co-authorship network of co-authors of J. P. Lamagnere

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Lamagnere. A scholar is included among the top collaborators of J. P. Lamagnere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Lamagnere. J. P. Lamagnere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cambier, Nathalie, N Balitrand, Thierry Leblanc, et al.. (2001). All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia. The Hematology Journal. 2(2). 97–102. 5 indexed citations
2.
Cambier, Nathalie, M. H. Schlageter, Thierry Leblanc, et al.. (2001). All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia.. PubMed. 2(2). 97–102. 5 indexed citations
3.
Benboubker, Lotfi, C Valat, Claude Linassier, et al.. (2000). A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels. Annals of Oncology. 11(11). 1485–1491. 31 indexed citations
4.
Linassier, Claude, Carole Barin, G. Calais, et al.. (2000). Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Annals of Oncology. 11(10). 1289–1294. 56 indexed citations
5.
Michel, Gérard, Judith Landman‐Parker, Marie-Françoise Auclerc, et al.. (2000). Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 18(7). 1517–1524. 34 indexed citations
6.
Benboubker, Lotfi, Claude Linassier, Martine Delain, et al.. (1998). Mediastinal Large-Cell Lymphoma with Sclerosis Refractory to Conventional Chemotherapy can Respond after Daily Oral Cyclophosphamide. Leukemia & lymphoma. 29(1-2). 199–203. 1 indexed citations
7.
Cartron, Guillaume, Claude Linassier, B Desablens, et al.. (1998). CD5 Negative B-cell Chronic Lymphocytic Leukemia: Clinical and Biological Features of 42 cases. Leukemia & lymphoma. 31(1-2). 209–216. 32 indexed citations
8.
Kravtzoff, Roger, et al.. (1996). Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells. European Journal of Clinical Pharmacology. 49(6). 465–470. 46 indexed citations
9.
Kravtzoff, Roger, Isabelle Desbois, Claude Linassier, et al.. (1996). Tolerance Evaluation of L -asparaginase loaded in red blood cells. European Journal of Clinical Pharmacology. 51(3-4). 221–225. 43 indexed citations
10.
Kravtzoff, Roger, et al.. (1996). Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells. European Journal of Clinical Pharmacology. 49(6). 465–470. 2 indexed citations
11.
Domenech, Jorge, Claude Linassier, Isabelle Desbois, et al.. (1994). Haemopoiesis of transplanted patients with autologous marrows assessed by long‐term marrow culture. British Journal of Haematology. 88(3). 488–496. 46 indexed citations
12.
Barthez, Marie Anne, et al.. (1993). [Late recurrence of supra- and infra-tentorial medulloblastoma].. PubMed. 50(3). 215–8. 1 indexed citations
13.
Colombat, P, C Binet, Claude Linassier, et al.. (1992). High Dose Chemotherapy with Autologous Marrow Transplantation in Follicular Lymphomas. Leukemia & lymphoma. 7(sup1). 3–6. 12 indexed citations
14.
Linassier, Claude, et al.. (1992). Simultaneous occurrence of acute myelogenous leukemia and seminoma of the testis. Cancer Chemotherapy and Pharmacology. 30(3). 233–234. 4 indexed citations
15.
Desbois, Isabelle, et al.. (1992). Immunological Response to L-Asparaginase Loaded into Red Blood Cells. PubMed. 326. 175–182. 11 indexed citations
16.
Colombat, Philippe, Norbert Claude Gorin, C Binet, et al.. (1990). The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.. Journal of Clinical Oncology. 8(4). 630–637. 67 indexed citations
17.
Colombat, Philippe, Claude Linassier, C Binet, et al.. (1989). High dose chemotherapy including vepeside, cyclophosphamide and carboplatin with autologous bone marrow transplantation in one case of chemoresistant testicular cancer. Biomedicine & Pharmacotherapy. 43(6). 455–456. 1 indexed citations
18.
19.
Maupas, P, J. P. Lamagnere, F Lamisse, & J Laugier. (1976). Botulisme de Type C. Intérêt de la Recherche de la Toxémie. Médecine et Maladies Infectieuses. 6(6). 207–210. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Desbois Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Norbert-Claude Gorin Breakdown of academic impact, for papers by Jacopo Olivieri Breakdown of academic impact, for papers by Alessia Tabarrini Breakdown of academic impact, for papers by S Murea Breakdown of academic impact, for papers by Brent Kern Breakdown of academic impact, for papers by Ivan P. Law Breakdown of academic impact, for papers by Agnès Chassevent Breakdown of academic impact, for papers by Gerlinde Mitterbauer‐Hohendanner
Rankless by CCL
2026